Discontinued — last reported Q2 '24
ResMed SaaS — Goodwill (note 5) decreased by 0.3% to $2.08B in Q2 2024 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $2.10B to $2.08B. Over 3 years (FY 2021 to FY 2024), SaaS — Goodwill (note 5) shows an upward trend with a 17.6% CAGR.
An increase typically reflects recent strategic acquisitions, while a decrease may indicate impairment charges or write-downs due to underperformance.
This metric represents the carrying value of goodwill specifically allocated to the Software-as-a-Service (SaaS) busines...
Comparable to goodwill balances in software or digital health segments of medical device peers, often evaluated relative to segment-specific return on invested capital.
rmd_segment_saas_goodwill_note_5| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.29B | $1.29B | $1.29B | $1.29B | $1.29B | $1.29B | $2.10B | $2.11B | $2.10B | $2.08B | $2.11B | $2.09B | $2.08B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +62.2% | +0.7% | -0.7% | -1.2% | +1.7% | -0.9% | -0.3% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +62.2% | +63.3% | +62.2% | +60.3% | +0.5% | -1.1% | -0.7% |